Kisspeptin-10LibidoSafety Rating 7/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 10mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Ascension PeptidesBest $/mgCOA ✓ · 3P | $29.00 | $2.90 | Apr 16, 2026 | Buy → |
| Puratek PeptidesCOA ✓ · 3P | $35.96 | $3.60 | May 19, 2026 | Buy → |
| SomaChemsCOA ✓ · 3P | $47.99 | $4.80 | May 14, 2026 | Buy → |
| Pantheon PeptidesCOA ✓ · 3P | $61.56 | $6.16 | Apr 23, 2026 | Buy → |
| Core PeptidesCOA ✓ · 3P | $63.00 | $6.30 | Apr 16, 2026 | Buy → |
Overview
About Kisspeptin-10
Mechanism of action
Endogenous neuropeptide; binds KISS1R (GPR54); potent stimulator of GnRH release, driving LH and FSH surges; key regulator of reproductive axis; also inhibits cancer metastasis.
Safety profile
Injection site reactions; potential LH/FSH overstimulation. Generally well-tolerated. Long-term data limited. · Multiple human clinical studies; well-tolerated; short-acting; no serious adverse events
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Kisspeptin-10 below your target.
Related pages
More on Kisspeptin-10
Research
Studies & key findings
- Kisspeptin-10, the shortest bioactive form of kisspeptin (a GPR54/KISS1R ligand), robustly stimulates LH pulse frequency in healthy men at all tested IV doses; a continuous infusion of 1.5 µg/kg/h increased LH pulse frequency and significantly elevated testosterone, identifying its therapeutic potential as an LH/testosterone axis modulator.
- Responsiveness to kisspeptin-10 shows pronounced sexual dimorphism: robust LH/FSH release occurs in men at all cycle phases and in women only during the preovulatory phase — not during the follicular phase — indicating cycle-phase sensitivity must be accounted for in reproductive disorder treatment protocols.